Biora Therapeutics Home
Activate the mobile navigation

Reimagining therapeutic delivery

We’re innovating smart-pill technologies designed to deliver the right dose to the right place, safely.

About Biora

NaviCap™ Targeted Oral Delivery Platform

Treatment at the site of disease in the GI tract could improve outcomes for patients with inflammatory bowel disease

Learn More
 
popover=true popoverAnimateThumbnail=true videoFoam=true”> 

BioJet™ Systemic Oral Delivery Platform

Needle-free, oral delivery of large molecules designed to replace injection for better management of chronic diseases.

Learn More
 
popover=true popoverAnimateThumbnail=true videoFoam=true”> 

Press Releases

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update
Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer
See More

Publications

Potential effects of food on a novel Drug Delivery System (DDS) to deliver therapeutic compound into the colon
#Targeted Therapeutics
Development of a novel Drug Delivery System (DDS) to deliver drugs directly to the colonic mucosa to improve efficacy and reduce systemic exposure for the treatment of ulcerative colitis (UC)
#Targeted Therapeutics
A scintigraphic study to evaluate the localization and delivery function of a Drug Delivery System (DDS) device in patients with active ulcerative colitis in fasted state
#Targeted Therapeutics
See More